adastrahold2023-01-27T23:07:09+00:00Adastra Receives Controlled Substances Dealer’s Licenseadastrahold2023-01-27T23:07:09+00:00August 31, 2022|
adastrahold2023-01-27T21:37:20+00:00Adastra Signs Option to Terminate Legacy Supply Agreement to Streamline Operations and Maximize Revenue adastrahold2023-01-27T21:37:20+00:00August 30, 2022|
adastrahold2023-01-27T21:38:38+00:00Adastra Holdings Reports Record Second Quarter Results; Momentum Accelerating in Second Half of the Yearadastrahold2023-01-27T21:38:38+00:00August 26, 2022|
adastrahold2023-01-27T21:39:57+00:00Adastra Announces Grant of Stock Optionsadastrahold2023-01-27T21:39:57+00:00August 23, 2022|
adastrahold2023-01-27T21:41:48+00:00Adastra Expands Market Footprint Through Receipt of Medical Sales License from Health Canadaadastrahold2023-01-27T21:41:48+00:00August 17, 2022|
adastrahold2023-01-27T21:45:43+00:00Adastra Holdings Continues to Execute on Transformational Strategy; New Product Launches; Outlines Growth Strategyadastrahold2023-01-27T21:45:43+00:00June 29, 2022|
adastrahold2023-01-27T23:11:15+00:00Adastra Holdings Reports First Quarter Resultsadastrahold2023-01-27T23:11:15+00:00May 30, 2022|
adastrahold2023-01-27T21:30:47+00:00Adastra Holdings Announces New Directoradastrahold2023-01-27T21:30:47+00:00May 17, 2022|
